Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:428-429 (21 August), doi:10.1136/bmj.38201.410255.55 (published 3 August 2004)
Carolyn Day, doctoral candidate1, Louisa Degenhardt, lecturer1, Stuart Gilmour, statistician1, Wayne Hall, professor2
1 National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia, 2 Office of Public Policy and Ethics, Institute for Molecular Bioscience, University of Queensland, St Lucia, Brisbane, QLD 4072, Australia
Correspondence to: C Day carolyn.day{at}unsw.edu.au
This "heroin shortage" provided a natural experiment in which to examine the effect of substantial changes in price and availability on injecting drug use and its associated harms in Australia's largest heroin market,2 a setting in which harm reduction strategies were widely used. Publicly funded needle and syringe programmes were introduced to Australia in 1987, and methadone maintenance programmes, which were established in the 1970s, were significantly expanded in 1985 and again in 1999.
The number of needles and syringes distributed in NSW decreased around the onset of the heroin shortage (figure) and the reduction was sustained until the end of the period for which data were available. The number of needles distributed decreased from around 3.1 million per quarter immediately before the heroin shortage to just under 2.2 million in mid-2002a decrease of around 28%. Time series analysis on monthly data from major needle and syringe programmes suggested that this decline was not a seasonal effect and was tied closely to the onset of the shortage (analysis available on request).
|
We relied on secondary data sources as indirect measures of the prevalence of injecting drug use. None the less, the coherent pattern of changes outlined in this study is not easily explained by any other hypotheses and is consistent with other research on the consequences of the heroin shortage.3
Our findings are also consistent with a reduction in notifications of hepatitis C among people aged 15-19 years, which started around the time of the reduction in heroin supply.4 Nearly all such infections are related to injecting drug use, and there are no alternative explanations for the decrease in notifications, which was not predicted by mathematical models of the hepatitis C epidemic in Australia.5 However, the true impact of reduced supply is unlikely to be detectable for some time. Reduction in injecting drug use, as indicated by reduced output in the needle and syringe programmes, would be consistent with reduction in such infections at the population level. We are currently exploring further impacts of the shortage on overdose, treatment, and crime.
|
We thank the many agencies and individuals who provided advice and data for inclusion in the study; Linette Collins, Amy Gibson, and Elizabeth Conroy for assistance with the project; and Owen Westcott and Jenny Iverson from the AIDS and Infectious Diseases Branch of NSW Health for facilitating access to NSW notification and programme data. We also thank Greg Dore, Lisa Maher, and Margaret MacDonald for comments on an earlier draft of the paper.
Contributors: CD (guarantor), LD, and WH conceived the study. LD supervised the research. CD led the writing. SG conducted the analysis for the study. All authors helped to conceptualise ideas, interpret findings, and review drafts of the manuscript.
Funding: This work was completed as part of a larger project funded by the Australian National Drug Law Enforcement Research Fund (NDLERF). The National Drug and Alcohol Research Centre is funded by the Australian Government Department of Health and Ageing. CD was funded by a postgraduate award from the Australian Government Department of Health and Ageing.
Competing interests: None declared.
Ethical approval: The study was approved by the University of New South Wales human research ethics committee and the human research ethics committees of the South Eastern Sydney Area Health Service, South Western Area Health Service, and Central Sydney Area Health Service.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses